{
  "id": 15537104,
  "title": "Pharma Q2 Outlook: Pricing pressure, US competition to weigh on select players",
  "url": "https://urgent.news/2026/10/19/pharma-q2-outlook-pricing-pressure-us-competition-to-weigh-on-select",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-19T00:29:30.000Z",
  "source": {
    "name": "The Economic Times - Top News",
    "slug": "the-economic-times-top-news",
    "url": "https://economictimes.indiatimes.com/markets/stocks/earnings/indias-pharmaceutical-companies-to-report-mixed-results-as-domestic-growth-offsets-pricing-pressures/articleshow/135037267.cms"
  },
  "original_language": "en",
  "account": null,
  "summary": "India's pharmaceutical companies are expected to have a mixed performance in the upcoming September quarter. Companies like Sun Pharmaceutical Industries and Aurobindo Pharma are likely to report good growth. In contrast, Dr Reddy's Laboratories and Lupin may face challenges due to increased competition and a high base. Pricing pressure and elevated raw material costs are also expected to impact…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}